Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder
Description
Business Wire (English); 04/18/2024(AN bizwire.20240418781685)Business Source Corporate Plus